The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance

被引:194
作者
Zucca, Emanuele [1 ]
Bertoni, Francesco [1 ,2 ]
机构
[1] Osped San Giovanni Bellinzona, Lymphoma Unit, Div Res, Oncol Inst Southern Switzerland IOSI, CH-6500 Bellinzona, Switzerland
[2] Oncol Res Inst, Lymphoma & Genom Res Program, Bellinzona, Switzerland
关键词
MARGINAL ZONE LYMPHOMA; B-CELL LYMPHOMA; HELICOBACTER-PYLORI ERADICATION; HEPATITIS-C VIRUS; PRIMARY GASTRIC-LYMPHOMA; TISSUE LYMPHOMA; PHASE-II; CLINICAL ACTIVITY; CHROMOSOMAL-ABERRATION; VARIABLE FREQUENCIES;
D O I
10.1182/blood-2015-12-624304
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Extranodal marginal zone (MZ) B-cell lymphomas of the mucosa-associated lymphoid tissue (MALT) arise from lymphoid populations that are induced by chronic inflammation in extranodal sites. The best evidence of an etiopathogenetic link is provided by the association between Helicobacter pylori-positive gastritis and gastric MALT lymphoma. Indeed, successful eradication of this microorganism with antibiotics can be followed by gastric MALT lymphoma regression in most cases. Other microbial agents have been implicated in the pathogenesis of MZ lymphoma arising at different sites. Apart from gastric MALT lymphoma, antibiotic therapies have been adequately tested only in ocular adnexal MALT lymphomas where upfront doxycycline may be a reasonable and effective initial treatment of patients with Chlamydophila psittaci-positive lymphoma before considering more aggressive strategies. In all other instances, antibiotic treatment of nongastric lymphomas remains investigational. Indeed, there is no clear consensus for the treatment of patients with gastric MALT lymphoma requiring further treatment beyond H pylori eradication or with extensive disease. Both radiotherapy and systemic treatments with chemotherapy and anti-CD20 antibodies are efficacious and thus the experience of individual centers and each patient's preferences in terms of adverse effects are important parameters in the decision process.
引用
收藏
页码:2082 / 2092
页数:11
相关论文
共 148 条
  • [1] Prevalence of Achromobacter xylosoxidans in pulmonary mucosa-associated lymphoid tissue lymphoma in different regions of Europe
    Adam, Patrick
    Czapiewski, Piotr
    Colak, Seba
    Kosmidis, Perikles
    Tousseyn, Thomas
    Sagaert, Xavier
    Boudova, Ludmila
    Okon, Krzysztof
    Morresi-Hauf, Alicia
    Agostinelli, Claudio
    Pileri, Stefano
    Pruneri, Giancarlo
    Martinelli, Giovanni
    Du, Ming-Qing
    Fend, Falko
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (06) : 804 - 810
  • [2] Bruton Tyrosine Kinase Inhibitor Ibrutinib (PCI-32765) Has Significant Activity in Patients With Relapsed/Refractory B-Cell Malignancies
    Advani, Ranjana H.
    Buggy, Joseph J.
    Sharman, Jeff P.
    Smith, Sonali M.
    Boyd, Thomas E.
    Grant, Barbara
    Kolibaba, Kathryn S.
    Furman, Richard R.
    Rodriguez, Sara
    Chang, Betty Y.
    Sukbuntherng, Juthamas
    Izumi, Raquel
    Hamdy, Ahmed
    Hedrick, Eric
    Fowler, Nathan H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (01) : 88 - 94
  • [3] Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms
    Al-Saleem, T
    Al-Mondhiry, H
    [J]. BLOOD, 2005, 105 (06) : 2274 - 2280
  • [4] Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection
    Ambrosetti, A
    Zanotti, R
    Pattaro, C
    Lenzi, L
    Chilosi, M
    Caramaschi, P
    Arcaini, L
    Pasini, F
    Biasi, D
    Orlandi, E
    D'Adda, M
    Lucioni, M
    Pizzolo, G
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (01) : 43 - 49
  • [5] [Anonymous], 2015, J CLIN EXP PATHOL
  • [6] [Anonymous], ONCOLOGY WILLISTON P
  • [7] t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth
    Ansell, Stephen M.
    Akasaka, Takashi
    McPhail, Ellen
    Manske, Michelle
    Braggio, Esteban
    Price-Troska, Tammy
    Ziesmer, Steven
    Secreto, Frank
    Fonseca, Rafael
    Gupta, Mamta
    Law, Mark
    Witzig, Thomas E.
    Dyer, Martin J. S.
    Dogan, Ahmet
    Cerhan, James R.
    Novak, Anne J.
    [J]. BLOOD, 2012, 120 (19) : 3949 - 3957
  • [8] Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT
    Arcaini, L.
    Burcheri, S.
    Rossi, A.
    Paulli, M.
    Bruno, R.
    Passamonti, F.
    Brusamolino, E.
    Molteni, A.
    Pulsoni, A.
    Cox, M. C.
    Orsucci, L.
    Fabbri, A.
    Frezzato, M.
    Voso, M. T.
    Zaja, F.
    Montanari, F.
    Merli, M.
    Pascutto, C.
    Morra, E.
    Cortelazzo, S.
    Lazzarino, M.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (02) : 346 - 350
  • [9] Anti-Lymphoma Activity of Interferon-Free Antiviral Treatment in Patients with Indolent B-Cell Lymphomas Associated with Hepatitis C Virus Infection
    Arcaini, Luca
    Besson, Caroline
    Peveling-Oberhag, Jan
    Loustaud-Ratti, Veronique
    Rattotti, Sara
    Ferretti, Virginia
    Zignego, Anna Linda
    Casato, Milvia
    Merli, Michele
    Hermine, Olivier
    Visco, Carlo
    [J]. BLOOD, 2015, 126 (23)
  • [10] Indolent B-Cell Lymphomas Associated with HCV Infection: Clinical and Virological Features and Role of Antiviral Therapy
    Arcaini, Luca
    Merli, Michele
    Volpetti, Stefano
    Rattotti, Sara
    Gotti, Manuel
    Zaja, Francesco
    [J]. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,